Skip to main content
. 2024 Sep 12;17:258. doi: 10.1186/s13104-024-06904-7

Table 1.

Sociodemographic description of both treatment groups (nIG = 31, nCG = 33)

IG CG
N (N in %) N (N in %)
Female 23 (74.2%) 21 (63.6%)
Disorder
 Alzheimer’s Disease 6 (19.4%) 16 (48.5%)
 Vascular dementia 2 (06.5%) 1 (03.0%)
 Unspecified 7 (22.6%) 3 (09.1%)
 Dementia in other diseases 16 (51.6%) 13 (39.4%)
Stage of severity (MMSE)
 Mild 5 (16.1%) 3 (09.1%)
 Moderate 9 (29.0%) 6 (18.2%)
 Severe 17 (54.8%) 24 (72.7%)
Psychopharmacological treatment 25 (80.7%) 25 (75.8%)
Treatment with cortisone 0 (00.0%) 0 (00.0%)
Treatment with beta-blocker 15 (48.4%) 9 (27.3%)
M SD M SD
Age 83.00 08.41 84.03 07.09
MMSE score 08.10 01.50 07.00 01.23
 Mild 20.40 0.68 22.33 2.40
 Moderate 14.22 1.10 12.33 1.31
 Severe 1.24 0.55 3.29 0.75

Note. Intervention group (IG), control group (CG), M and SD represent the mean and standard deviation. Stage of severity was assessed with the German version of the Mini-Mental State examination (MMSE, Folstein et al., 1975). The severity of the stages was defined as follows: mild: ≥19, moderate: 10–18, severe: ≤9